In oncology, some milestones arrive with applause. Others arrive quietly. This year, one of the most important cancer drugs of the modern era begins to lose its monopoly. Nivolumab, one of the…
If you ask Robert Weinberg how his career began, he will not tell you a story of grand plans or carefully plotted ambition. He will tell you it was “a series of…
Dr. Nageatte Ibrahim has spent her career at the intersection of oncology, science, and medicine, with achievements resulting in global impacts. Trained as a physician and scientist, she played a central role…
China’s oncologists want to see robust evidence before putting their faith in traditional remedies. Practitioners of traditional Chinese medicine struggle with concepts of experimental medicine and animal models. But interest is growing…
